Intranasal nano-immunotherapy for glioma: bypassing the blood–brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation

Leina Li, Moli Wu, Liya Li

Open source

DOI
10.3389/fimmu.2026.1950362
Published
2026-10-20
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1950362,
  title = {Intranasal nano-immunotherapy for glioma: bypassing the blood–brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation},
  author = {Leina Li and Moli Wu and Liya Li},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1950362},
  url = {https://doi.org/10.3389/fimmu.2026.1950362}
}

RIS

TY  - JOUR
TI  - Intranasal nano-immunotherapy for glioma: bypassing the blood–brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation
AU  - Leina Li
AU  - Moli Wu
AU  - Liya Li
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1950362
UR  - https://doi.org/10.3389/fimmu.2026.1950362
ER  - 

APA

Li, L., Wu, M., & Li, L. (2026). Intranasal nano-immunotherapy for glioma: bypassing the blood–brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1950362

Source records